Pamelor Related Published Studies
Well-designed clinical trials related to Pamelor (Nortriptyline)
Nortriptyline for treating enuresis in ADHD--a randomized double-blind controlled
clinical trial. [2012]
Topiramate plus nortriptyline in the preventive treatment of migraine: a controlled study for nonresponders. [2011.10.19]
Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. [2011.07]
Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation. [2011.06.09]
A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine. [2009.12]
Suicidal ideation during treatment of depression with escitalopram and nortriptyline in genome-based therapeutic drugs for depression (GENDEP): a clinical trial. [2009.10.15]
Sensory complaints of the upper extremities in multiple sclerosis: relative efficacy of nortriptyline and transcutaneous electrical nerve stimulation. [2009.05]
Sexual function in postpartum women treated for depression: results from a randomized trial of nortriptyline versus sertraline. [2009.03]
Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. [2009.03]
Vitamin B12 may be more effective than nortriptyline in improving painful diabetic neuropathy. [2009]
[Association between polymorphisms of Val66Met in the BDNF gene and the response to escitalopram and nortriptyline treatment in the light of the neurodevelopmental hypothesis of depression] [2008.11]
Continuation/maintenance treatment with nortriptyline versus combined nortriptyline and ECT in late-life psychotic depression: a two-year randomized study. [2008.06]
Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial. [2008.05.31]
Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial. [2007.12]
Morphine, nortriptyline and their combination vs. placebo in patients with chronic lumbar root pain. [2007.07]
Belief about drug assignment and abstinence in treatment of cigarette smoking using nortriptyline. [2007.04]
Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial--the GONIP Trial. [2006.08]
Postpartum depression: a randomized trial of sertraline versus nortriptyline. [2006.08]
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. [2006.07]
A controlled trial of nortriptyline, sustained-release bupropion and placebo for smoking cessation: preliminary results. [2006]
Efficacy of bupropion and nortriptyline for smoking cessation among people at risk for or with chronic obstructive pulmonary disease. [2005.10.24]
Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance. [2005.10]
Cost-effectiveness of bupropion, nortriptyline, and psychological intervention in smoking cessation. [2005.10]
A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression. [2005.01]
A randomized trial of nortriptyline combined with transdermal nicotine for smoking cessation. [2004.11.08]
Extended nortriptyline and psychological treatment for cigarette smoking. [2004.11]
No evidence of increased adverse drug reactions in cytochrome P450 CYP2D6 poor metabolizers treated with fluoxetine or nortriptyline. [2004.01]
Thyroid indices and response to fluoxetine and nortriptyline in major depression. [2003.12]
Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline. [2003.12]
Double-blind comparison of fluoxetine and nortriptyline in the treatment of moderate to severe major depression. [2003.10]
A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender. [2003.07]
Treatment of poststroke generalized anxiety disorder comorbid with poststroke depression: merged analysis of nortriptyline trials. [2003.05]
Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine. [2003.03]
Lithium augmentation of nortriptyline for subjects resistant to multiple antidepressants. [2003.02]
Single-blind comparison of venlafaxine and nortriptyline in elderly major depression. [2003.02]
Effect of nortriptyline and paroxetine on CYP2D6 activity in depressed elderly patients. [2002.10]
Stopping smoking: a prospective, randomized, double-blind study comparing nortriptyline to placebo. [2002.08]
Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. [2002.07]
Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline. [2002.06]
Effects of nortriptyline and paroxetine on postural sway in depressed elderly patients. [2002.03]
Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate. [2002]
A common P-glycoprotein polymorphism is associated with nortriptyline-induced postural hypotension in patients treated for major depression. [2002]
Well-designed clinical trials possibly related to Pamelor (Nortriptyline)
Preliminary assessment of a neuropathic pain treatment and referral algorithm for patients with cancer. [2011.12]
Systematic Review and Meta-Analysis of Efficacy, Safety, and Tolerability Data from Randomized Controlled Trials of Drugs Used to Treat Postherpetic Neuralgia (December). [2011.11.15]
The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease. [2011.10]
Quantitative approaches for assessment of white matter hyperintensities in elderly populations. [2011.08.30]
Variation in GNB3 predicts response and adverse reactions to antidepressants. [2011.07]
Changes in body weight during pharmacological treatment of depression. [2011.04]
Treatment of depressive symptoms in Parkinson's disease. [2011.03]
Depression in Parkinson's disease: symptom improvement and residual symptoms after acute pharmacologic management. [2011.03]
Convergent animal and human evidence suggests a role of PPM1A gene in response to antidepressants. [2011.02.15]
The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: a systematic review. [2011.02.12]
Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled
randomized trials. [2011]
Treatment of depressive symptoms in Parkinson's disease. [2011]
Stressful life events, cognitive symptoms of depression and response to antidepressants in GENDEP. [2010.12]
Measures of temperament and character are differentially impacted on by depression severity. [2010.10]
Personality disorders improve in patients treated for major depression. [2010.09]
Depression in Parkinson's Disease: Symptom Improvement and Residual Symptoms After Acute Pharmacologic Management. [2010.06.26]
History of suicide attempts among patients with depression in the GENDEP project. [2010.06]
Orosomucoid influences the response to antidepressants in major depressive disorder. [2010.04]
The impact of antidepressant treatment on cognitive functioning in depressed patients with Parkinson's disease. [2010.03]
A randomized controlled trial comparing the memory effects of continuation electroconvulsive therapy versus continuation pharmacotherapy: results from the Consortium for Research in ECT (CORE) study. [2010.02]
The clinical use of drugs influencing neurotransmitters in the brain to promote motor recovery after stroke; a Cochrane systematic review. [2009.12]
The cost-effectiveness of antidepressants for smoking cessation in chronic obstructive pulmonary disease (COPD) patients. [2009.12]
Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. [2009.11]
Body weight as a predictor of antidepressant efficacy in the GENDEP project. [2009.11]
The impact of treatment of depression on quality of life, disability and relapse in patients with Parkinson's disease. [2009.07.15]
Effect of concomitant pharmacotherapy on electroconvulsive therapy outcomes: short-term efficacy and adverse effects. [2009.07]
What mediates the effect of confrontational counselling on smoking cessation in smokers with COPD? [2009.07]
Moderation of antidepressant response by the serotonin transporter gene. [2009.07]
Pharmacokinetics and efficacy of fluvoxamine and amitriptyline in depression. [2009.05]
Efficacy of confronting smokers with airflow limitation for smoking cessation. [2009.04]
Outcome of late-life depression after 3 years of sequential treatment. [2009.04]
Eighteen months of drug treatment for depression: predicting relapse and recovery. [2009.04]
A controlled trial of antidepressants in patients with Parkinson disease and depression. [2009.03.10]
Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE). [2009.02]
What mediates the effect of confrontational counselling on smoking cessation in smokers with COPD? [2009.01.15]
A controlled trial of antidepressants in patients with Parkinson disease and depression. [2008.12.17]
Outcome of late-life depression after 3 years of sequential treatment. [2008.11.24]
Antidepressant treatment is associated with a reduction in suicidal ideation and suicide attempts. [2008.08]
Antidepressant use in nonmajor depression: secondary analysis of a program to encourage active, rewarding lives for seniors (PEARLS), a randomized controlled trial in older adults from 2000 to 2003. [2008.03]
The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial. [2008.03]
Data Management and Design Issues in an Unmasked Randomized Trial of Electroconvulsive Therapy for Relapse Prevention of Severe Depression: The Consortium for Research in Electroconvulsive Therapy Trial. [2007.12]
Efficacy of confrontational counselling for smoking cessation in smokers with previously undiagnosed mild to moderate airflow limitation: study protocol of a randomized controlled trial. [2007.11.15]
Risk factors for and correlates of poststroke depression following discontinuation of antidepressants. [2007.09]
DSM melancholic features are unreliable predictors of ECT response: a CORE publication. [2007.09]
Cerebral volume measurements and subcortical white matter lesions and short-term treatment response in late life depression. [2007.05]
Effect of antidepressant therapy on executive function after stroke. [2007.03]
Relapse during continuation pharmacotherapy after acute response to ECT: a comparison of usual care versus protocolized treatment. [2007.01]
Continuation electroconvulsive therapy vs pharmacotherapy for relapse prevention in major depression: a multisite study from the Consortium for Research in Electroconvulsive Therapy (CORE). [2006.12]
Aggressive behavior in patients with stroke: association with psychopathology and results of antidepressant treatment on aggression. [2006.06]
[Maintenance electroconvulsive therapy in elderly psychotic unipolar depression] [2006.04.08]
Genetic, developmental and personality correlates of self-mutilation in depressed patients. [2006.03]
Impact of cluster C personality disorders on outcomes of acute and maintenance treatment in late-life depression. [2005.09]
Tryptophan and tyrosine availability and response to antidepressant treatment in major depression. [2005.06]
Reversed diurnal variation in depression: associations with a differential antidepressant response, tryptophan: large neutral amino acid ratio and serotonin transporter polymorphisms. [2005.04]
Weight changes in postpartum women with remitted depression. [2005.03]
Estimating treatment effects from longitudinal clinical trial data with missing values: comparative analyses using different methods. [2004.12.15]
Bipolar II disorder: personality and outcome in two clinical samples. [2004.06]
Identifying depression in the first postpartum year: guidelines for office-based screening and referral. [2004.05]
Role functioning and symptom remission in women with postpartum depression after antidepressant treatment. [2003.12]
|
